Literature DB >> 1260785

A pharmacokinetically based phase I-II study of single-dose actinomycin D (NSC-3053).

R S Benjamin, S W Hall, M A Burgess, W L Wheeler, W K Murphy, G R Blumenschein, J A Gottlieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1260785

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  4 in total

Review 1.  The role of antitumor antibiotics in current oncologic practice.

Authors:  H L Davis; D D von Hoff; J E Henney; M Rozencweig
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

Review 2.  Chemotherapy of malignant melanoma.

Authors:  R S Benjamin
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

Review 3.  Combined modality therapy of malignant melanoma.

Authors:  E M Hersh; J U Gutterman; C M McBride
Journal:  World J Surg       Date:  1979-07-30       Impact factor: 3.352

4.  Accidental actinomycin D overdosage in man, a case report.

Authors:  I A Choonara; S Kendall-Smith; C C Bailey
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.